<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">Furthermore, we tested the drug efficacy of S416 in Zika virus-infected AG6 adult mice. The data in Fig. S7A showed that S416 (10 mg/kg) could successfully rescue 25% of mice from high lethal dose infection of the Zika virus. Interestingly, the only survival mouse is male (Fig. S7B) but not female (Fig. S7C), which coincide with previous findings that female mice and women were more susceptible to Zika infection (Coelho et al., 
 <xref ref-type="bibr" rid="CR9">2016</xref>; Tang et al., 
 <xref ref-type="bibr" rid="CR53">2016</xref>; Carroll et al., 
 <xref ref-type="bibr" rid="CR3">2017</xref>).
</p>
